Serine/threonine kinase inhibitors
US8637537B2 · kind B2 · utility
1Cited by
25References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2012 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Aug 24, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds having the formula I wherein A, Z, R1a, R1b, R2, R3, R4, R5, R6, R7, R9, R10, Ra, Rb and n are as defined herein are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.